Comparison of the effects of edoxaban, an oral factor Xa inhibitor, and other anticoagulants on thrombin generation

被引：0
|
作者：
Mendell, J. [1 ]
Li, Y. [1 ]
Samama, M. M. [2 ]
Halim, A-B [1 ]
Song, S. [1 ]
Depasse, F. [3 ]
Kunitada, S. [4 ]
机构：
[1] Daiichi Sankyo Pharma Dev, Edison, NJ USA
[2] Hosp Hotel Dieu, Paris, France
[3] Biomnis Lab, Ivry, France
[4] Daiichi Sankyo Co Ltd, Tokyo, Japan
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2011年 / 9卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P-WE-176
引用
收藏
页码：575 / 575
页数：1
相关论文
共 50 条
  • [1] Edoxaban, a Novel Oral Factor Xa Inhibitor
    Minor, Chelsea
    Tellor, Katie B.
    Armbruster, Anastasia L.
    ANNALS OF PHARMACOTHERAPY, 2015, 49 (07) : 843 - 850
  • [2] Laboratory Measurements of the Oral Direct Factor Xa Inhibitor Edoxaban Comparison of Prothrombin Time, Activated Partial Thromboplastin Time, and Thrombin Generation Assay
    Morishima, Yoshiyuki
    Kamisato, Chikako
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2015, 143 (02) : 241 - 247
  • [3] Edoxaban A New Oral Direct Factor Xa Inhibitor
    Camm, A. John
    Bounameaux, Henri
    DRUGS, 2011, 71 (12) : 1503 - 1526
  • [4] Prolongation of clot lysis time by a direct thrombin inhibitor melagatran mediated by paradoxical enhancement of thrombin generation: comparison with a direct factor Xa inhibitor edoxaban
    Morishima, Yoshiyuki
    Kamisato, Chikako
    Honda, Yuko
    BLOOD COAGULATION & FIBRINOLYSIS, 2021, 32 (03) : 209 - 215
  • [5] Factor Xa and thrombin as targets for new oral anticoagulants
    Weitz, Jeffrey I.
    THROMBOSIS RESEARCH, 2011, 127 : S5 - S12
  • [6] Comparison of antithrombotic and haemorrhagic effects of edoxaban, an oral direct factor Xa inhibitor, with warfarin and enoxaparin in rats
    Morishima, Yoshiyuki
    Honda, Yuko
    Kamisato, Chikako
    Tsuji, Naoki
    Kita, Akemi
    Edo, Naoko
    Shibano, Toshiro
    THROMBOSIS RESEARCH, 2012, 130 (03) : 514 - 519
  • [7] Edoxaban: An Update on the New Oral Direct Factor Xa Inhibitor
    Bounameaux, Henri
    Camm, A. John
    DRUGS, 2014, 74 (11) : 1209 - 1231
  • [8] Edoxaban: An Update on the New Oral Direct Factor Xa Inhibitor
    Henri Bounameaux
    A. John Camm
    Drugs, 2014, 74 : 1209 - 1231
  • [9] Comparison of the effects of edoxaban, an oral direct factor Xa inhibitor, on venous thromboembolism between patients with and without cancer
    Ikeda, Satoshi
    Koga, Seiji
    Yamagata, Yuki
    Eguchi, Masamichi
    Sato, Daisuke
    Muroya, Takahiro
    Yonekura, Tsuyoshi
    Tsuneto, Akira
    Yoshimuta, Tsuyoshi
    Koide, Yuji
    Kawano, Hiroaki
    Maemura, Koji
    JOURNAL OF CARDIOLOGY, 2018, 72 (1-2) : 120 - 127
  • [10] Effects of Food on the Pharmacokinetics of Edoxaban, an Oral Direct Factor Xa Inhibitor, in Healthy Volunteers
    Mendell, Jeanne
    Tachibana, Masaya
    Shi, Minggao
    Kunitada, Satoshi
    JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 51 (05): : 687 - 694
12345